Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis

Joseph Ventura, Gerhard S Hellemann, April D Thames, Vanessa Koellner, Keith H Nuechterlein, Joseph Ventura, Gerhard S Hellemann, April D Thames, Vanessa Koellner, Keith H Nuechterlein

Abstract

Background: Neurocognitive functioning in schizophrenia has received considerable attention because of its robust prediction of functional outcome. Psychiatric symptoms, in particular negative symptoms, have also been shown to predict functional outcome, but have garnered much less attention. The high degree of intercorrelation among all of these variables leaves unclear whether neurocognition has a direct effect on functional outcome or whether that relationship to functional outcome is partially mediated by symptoms.

Methods: A meta-analysis of 73 published English language studies (total n=6519) was conducted to determine the magnitude of the relationship between neurocognition and symptoms, and between symptoms and functional outcome. A model was tested in which symptoms mediate the relationship between neurocognition and functional outcome. Functional outcome involved measures of social relationships, school and work functioning, and laboratory assessments of social skill.

Results: Although negative symptoms were found to be significantly related to neurocognitive functioning (p<.01) positive symptoms were not (p=.97). The relationship was moderate for negative symptoms (r=-.24, n=4757, 53 studies), but positive symptoms were not at all related to neurocogniton (r=.00, n=1297, 25 studies). Negative symptoms were significantly correlated with functional outcome (r=-.42, p<.01), and again the correlation was higher than for positive symptoms (r=-.03, p=.55). Furthermore, our findings support a model in which negative symptoms significantly mediate the relationship between neurocognition and functional outcome (Sobel test p<.01).

Conclusions: Although neurocognition and negative symptoms are both predictors of functional outcome, negative symptoms might at least partially mediate the relationship between neurocognition and outcome.

Conflict of interest statement

Conflict of interest

None of the authors has a financial conflict of interest.

Figures

Fig. 1
Fig. 1
Typical mediation model.

References

    1. Addington J, Addington D. Facial affect recognition and information processing in schizophrenia and bipolar disorder. Schizophrenia Research. 1998a;32(3):171–181.
    1. Addington J, Addington D. Visual attention and symptoms in schizophrenia: a 1-year follow-up. Schizophrenia Research. 1998b;34(1–2):95–99.
    1. Addington J, Addington D. Neurocognitive and social functioning in schizophrenia. Schizophrenia Bulletin. 1999;25(1):173–182.
    1. Addington J, Addington D. Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study. Schizophrenia Research. 2000;44:47–56.
    1. Addington J, Addington D, Maticka-Tyndale E. Cognitive functioning and positive and negative symptoms in schizophrenia. Schizophr Res. 1991;5(2):123–134.
    1. Addington J, Addington D, Gasbarre L. Distractibility and symptoms in schizophrenia. Journal of Psychiatry & Neuroscience. 1997;22(3):180–184.
    1. Addington J, van Mastrigt S, Addington D. Patterns of premorbid functioning in first-episode psychosis: initial presentation. Schizophrenia Research. 2003;62:23–30.
    1. Aghevli MA, Blanchard JJ, Horan WP. The expression and experience of emotion in schizophrenia: a study of social interactions. Psychiatry Research. 2003;119(3):261–270.
    1. Albus M, Hubmann W, Wahlheim C, Sobizack N, Franz U, Mohr F. Contrasts in neuropsychological test profile between outpatients with first-episode schizophrenia. Acta Psychiutr Scand. 1996;94:87–93.
    1. Baron RM, Kenny DA. The moderator–mediator variable distinction in social psychological research: conceptual, strategic and statistical considerations. Journal of Personality and Social Psychology. 1986;51:1173–1182.
    1. Basso MR, Nasrallah HA, Olson SC, Bornstein RA. Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia. Schizophrenia Research. 1998;31(2–3):99–111.
    1. Bell MD, Mishara AL. Does negative symptom change relate to neurocognitive change in schizophrenia? Implications for targeted treatments. Schizophrenia Research. 2006;81(1):17–27.
    1. Bellack AS, Green MF, Cook JA, et al. Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop. Schizophrenia Bulletin. 2007;33(3):805.
    1. Beng-Choon H, Nopoulos P, Flaum M, Arndt S, Andreasen NC. Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. American Journal of Psychiatry. 1998;155:1196–1201.
    1. Berman I, Viegner B, Merson A, Allan E, Pappas D, Green AI. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia. Schizophrenia Research. 1997;25(1):1–10.
    1. Bilder RM, Goldman RS, Robinson D, et al. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. American Journal of Psychiatry. 2000;157:549–559.
    1. Bowie CR, Harvey PD, Moriarty PJ, Parrella M, White L, Davis KL. A comprehensive analysis of verbal fluency deficit in geriatric schizophrenia. Archives of Clinical Neuropsychology. 2004;19(2):289–303.
    1. Bowie CR, Reichenberg A, Patterson TL, Heaton RK, Harvey PD. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. American Journal of Psychiatry. 2006;163(3):418.
    1. Bozikas VP, Kosmidis MH, Anezoulaki D, Giannakou M, Karavatos A. Relationship of affect recognition with psychopathology and cognitive performance in schizophrenia. Journal of the International Neuropsychological Society. 2004 Jul;10(4):549–558.
    1. Bozikas VP, Kosmidis MH, Kafantari A, Gamvrula K, Vasiliadou E, Petrikis P, Fokas K, Karavatos A. Community dysfunction in schizophrenia: rate-limiting factors. Progress in Neuropsychopharmacology & Biological Psychiatry. 2006;30(3):463–470.
    1. Brazo P, Marié RM, Halbecq L, et al. Cognitive patterns in subtypes of schizophrenia. European Psychiatry. 2002;17(3):155–162.
    1. Brazo P, Delamillieure P, Morello R, Halbecq L, Marié RM, Dollfus S. Impairments of executive/attentional functions in schizophrenia with primary and secondary negative symptoms. Psychiatry Research. 2005;133(1):45–55.
    1. Brebion G, Smith MJ, Amador X, Malaspina D, Gorman JM. Clinical correlates of memory in schizophrenia: differential links between depression, positive and negative symptoms, and two types of memory impairment. American Journal of Psychiatry. 1997;154(11):1538–1543.
    1. Breier I, Schreiber JL, Dyer J, Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Archives of General Psychiatry. 1991;48:239–246.
    1. Brekke JS, Raine A, Thomson C. Cognitive and psychophysiological correlates of positive, negative, and disorganized symptoms in the schizophrenia spectrum. Psychiatry Research. 1995;57:241–250.
    1. Brekke J, Kay DD, Lee KS, Green MF. Biosocial pathways to functional outcome in schizophrenia. Schizophrenia Research. 2005;80(2–3):213–225.
    1. Bryson G, Whelahan HA, Bell M. Memory and executive function impairments in deficit syndrome schizophrenia. Psychiatry Research. 2001;102(1):29–37.
    1. Caligiuri MP, Hellige JB, Cherry BJ, Kwok W, Lulow LL, Lohr JB. Lateralized cognitive dysfunction and psychotic symptoms in schizophrenia. Schizophrenia Research. 2005;80(2–3):151–161.
    1. Cameron AM, Oram J, Geffen GM, Kavanagh DJ, McGrath JJ, Geffen LB. Working memory correlates of three symptom clusters in schizophrenia. Psychiatry Research. 2002;110(1):49–61.
    1. Carlsson R, Nyman H, Ganse G, Cullberg J. Neuropsychological functions predict 1 and 3-year outcome in first-episode psychosis. Acta Psychiatric Scandanavia. 2006;113:102–111.
    1. Carpenter WT. Clinical constructs and therapeutic discovery. Schizophrenia Research. 2004;72(1):69–73.
    1. Carpenter WT, Gold JM. Another view of therapy for cognition in schizophrenia. Biological Psychiatry. 2002;51(12):969–971.
    1. Carter C, Robertson L, Nordahl T, Chaderjian M, Kraft L, O'Shora-Celaya L. Spatial working memory deficits and their relationship to negative symptoms in unmedicated schizophrenia patients. Biological Psychiatry. 1996;40(9):930–932.
    1. Corrigan PW, Toomey R. Interpersonal problem solving and information processing in schizophrenia. Schizophrenia Bulletin. 1995;21(3):395–403.
    1. Cuesta MJ, Peralta V. Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia. Psychiatry Research. 1995;58(3):227–235.
    1. Cuesta MJ, Peralta V, Caro E, Leon J. Is poor insight in psychotic disorders associated with poor performance on the Wisconsin Card Sorting Test? American Journal of Psychiatry. 1995;152(9):1380–1382.
    1. Daban C, Amado I, Bayle F, et al. Correlation between clinical syndromes and neuropsychological tasks in unmedicated patients with recent onset schizophrenia. Psychiatry Res. 2002 Dec 15;113(1–2):83–92.
    1. Davidson L, McGlashan TH. The varied outcomes of schizophrenia. Canadian Journal of Psychiatry. 1997;42:34–43.
    1. Dibben CR, Rice C, Laws K, McKenna PJ. Is executive impairment associated with schizophrenic syndromes? A meta-analysis. Psychol Med. 2009 Mar;39(3):381–392.
    1. Dickerson E, Boronow JJ, Ringel N, Parente E. Social functioning and neurocognitive deficits in outpatients with schizophrenia: a 2-year follow-up. Schizophrenia Research. 1999a;37(1):13–20.
    1. Dickerson FB, Ringel N, Parente F. Predictors of residential independence among outpatients with schizophrenia. Psychiatr Serv. 1999b;50:515–519.
    1. Dickinson D, Coursey RD. Independence and overlap among neurocognitive correlates of community functioning in schizophrenia. Schizophrenia Research. 2002 Jul;56(1–2):161–170.
    1. Evans JD, Bond GR, Meyer PS, Kim HW, Lysaker PH, Gibson PJ, Tunis S. Cognitive and clinical predictors of success in vocational rehabilitation in schizophrenia. Schizophrenia Research. 2004;70(2–3):331–342.
    1. Franke P, Maier W, Hain C, Klingler T. Wisconsin Card Sorting Test: an indicator of vulnerability to schizophrenia? Schizophrenia Research. 1992;6(3):243–249.
    1. Friedman JI, Harvey PD, McGurk SR, et al. Correlates of change in functional status of institutionalized geriatric schizophrenic patients: focus on medical comorbidity. American Journal of Psychiatry. 2002;159:1388–1394.
    1. Gold JM. Cognitive deficits as treatment targets in schizophrenia. Schizophrenia Research. 2004 Dec 15;72(1):21–28.
    1. Gooding DC, Tallent KA. Nonverbal working memory deficits in schizophrenia patients: evidence of a supramodal executive processing deficit. Schizophrenia Research. 2004;68(2–3):189–201.
    1. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry. 1996;153(3):321–330.
    1. Green MF, Nuechterlein KH. Should schizophrenia be treated as a neurocognitive disorder? Schizophrenia Bulletin. 1999;25:309–318.
    1. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”? Schizophrenia Bulletin. 2000;26(1):119–136.
    1. Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophrenia Research. 2004 Dec 15;72(1):41–51.
    1. Guillem F, Bicu M, Bloom D, Wolf MA, Desautels R, Lalinec M, Kraus D, Debruille JB. Neuropsychological impairments in the syndromes of schizophrenia: a comparison between different dimensional models. Brain and Cognition. 2001;46(1–2):153–159.
    1. Hafdahl AR. Combining correlation matrices: simulation analysis of improved fixed-effects methods. Journal of Educational and Behavioral Statistics. 2007;32(2):180.
    1. Hammer MA, Katsanis J, Iacono WG. The relationship between negative symptoms and neuropsychological performance. Biological Psychiatry. 1995;37(11):828–830.
    1. Harvey PD, Howanitz E, Parrella M, White L, Davidson M, Mohs RC, Hoblyn J, Davis KL. Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites. American Journal of Psychiatry. 1998;155:1080–1086.
    1. Harvey PD, Green MF, Bowie C, Loebel A. The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements. Psychopharmacology. 2006;187(3):356–363.
    1. Heaton R, Paulsen JS, McAdams LA, Kuck J, Zisook S, Braff D, Harris MJ, Jeste DV. Neuropsychological deficits in schizophrenics: relationship to age, chronicity, and dementia. Archives of General Psychiatry. 1994;51:469–476.
    1. Hedges LV, Olkin I. Nonparametric estimators of effect size in metaanalysis. Psychological Bulletin. 1984;96(3):573–580.
    1. Herbener ES, Harrow M. Are negative symptoms associated with functioning deficits in both schizophrenia and nonschizophrenia patients? A 10-year longitudinal analysis. Schizophrenia Bulletin. 2004;30(4):813.
    1. Hofer A, Rettenbacher MA, Widschwendter CG, Kemmler G, Hummer M, Fleischhacker WW. Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder. European Archives of Psychiatry and Clinical Neuroscience. 2006;256(4):246–255.
    1. Hoff AL, Kremen WS. Neuropsychology in schizophrenia: an update. Current Opinion in Psychiatry. 2003;16:149–155.
    1. Hoff A, Svetina LC, Maurizio AM, Crow TJ, Spokes K. Familial cognitive deficits in schizophrenia. American Journal of Medical Genetics. 2005;133(5B)
    1. Hoffmann H, Kupper Z, Zbinden M, Hirsbrunner HP. Predicting vocational functioning and outcome in schizophrenia outpatients attending a vocational rehabilitation program. Social Psychiatry and Psychiatric Epidemiology. 2003;38(2):76–82.
    1. Howanitz E, Cicalese C, Harvey PD. Verbal fluency and psychiatric symptoms in geriatric schizophrenia. Schizophrenia Research. 2000;42(3):167–169.
    1. Keefe RS, Bilder RM, Harvey PD, et al. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology. 2006a Apr 19;
    1. Keefe RS, Seidman LJ, Christensen BK, et al. Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis. Biological Psychiatry. 2006b Jan 15;59(2):97–105.
    1. Kerns JG, Berenbaum H, Barch DM, Banich MT, Stolar N. Word production in schizophrenia and its relationship to positive symptoms. Psychiatry Research. 1999;87(1):29–37.
    1. Klingberg S, Wittorf A, Wiedemann G. Disorganization and cognitive impairment in schizophrenia: independent symptom dimensions? European Archives of Psychiatry and Clinical Neuroscience. 2006;256(8):532–540.
    1. Liddle PF, Morris DL. Schizophrenic syndromes and frontal lobe performance. Br J Psychiatry. 1991 Mar;158:340–345.
    1. Lipsey MW, Wilson DB. Practical Meta-analysis. Sage Pubns; 2001.
    1. Lysaker PH, Davis LW. Social function in schizophrenia and schizoaffective disorder: associations with personality, symptoms and neurocognition. Health Quality Life Outcomes. 2004;2:15.
    1. Malla AK, Norman RMG, Manchanda R, Townsend L. Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis. Psychological Medicine. 2002;32:1109–1119.
    1. McDaniel WF, Heindel CS, Harris DW. Verbal memory and negative symptoms of schizophrenia revisited. Schizophrenia Research. 2000;41(3):473–475.
    1. McGlashan TH, Fenton WS. The positive–negative distinction in schizophrenia: review of natural history validators. Archives of General Psychiatry. 1992;49:63–72.
    1. McGurk SR, Moriarty PJ, Harvey PD, Parrella M, White L, Davis KL. The longitudinal relationship of clinical symptoms, cognitive functioning, and adaptive life in geriatric schizophrenia. Schizophrenia Research. 2000;42(1):47–55.
    1. McGurk SR, Mueser KT, Harvey PD, LaPuglia R, Marder J. Cognitive and symptom predictors of work outcomes for clients with schizophrenia in supported employment. Psychiatric Services. 2003;54(8):1129–1135.
    1. Milev P. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. American Journal of Psychiatry. 2005;162(3):495–506.
    1. Minzenberg M, Poole J, Vinogradov S, Shenaut G, Ober B. Slowed lexical access is uniquely associated with positive and disorganised symptoms in schizophrenia. Cognitive Neuropsychiatry. 2003;8(2):107–127.
    1. Moore DJ, Savla GN, Woods SP, Jeste DV, Palmer BW. Verbal fluency impairments among middle-aged and older outpatients with schizophrenia are characterized by deficient switching. Schizophrenia Research. 2006;87(1–3):254–260.
    1. Moritz S, Andresen B, Jacobsen D, Mersmann K, Wilke U, Lambert M, Naber D, Krausz M. Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics. European Psychiatry. 2001a;16(6):354–361.
    1. Moritz S, Heeren D, Andresen B, Krausz M. An analysis of the specificity and the syndromal correlates of verbal memory impairments in schizophrenia. Psychiatry Research. 2001b;101(1):23–31.
    1. Müller BW, Sartory G, Bender S. Neuropsychological deficits and concomitant clinical symptoms in schizophrenia. European Psychologist. 2004;9(2):96–106.
    1. Nieuwenstein MR, Aleman A, de Haan EH. Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin Card Sorting Test Continuous Performance Test. Journal of Psychiatric Research. 2001 Mar–Apr;35(2):119–125.
    1. Norman RMG, Malla AK, Cortese L, et al. Symptoms and cognition as predictors of community functioning: a prospective analysis. American Journal of Psychiatry. 1999;156(3):400–405.
    1. Nuechterlein KH, Edell WS, Norris M, Dawson ME. Attentional vulnerability indicators, thought disorder, and negative symptoms. Schizophrenia Bulletin. 1986;12:408–426.
    1. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophrenia Research. 2004 Dec 15;72(1):29–39.
    1. Pantelis C, Harvey CA, Plant G, et al. Relationship of behavioural and symptomatic syndromes in schizophrenia to spatial working memory and attentional set-shifting ability. Psychological Medicine. 2004;34(04):693–703.
    1. Park S, Püschel J, Sauter BH, Rentsch M, Hell D. Spatial working memory deficits and clinical symptoms in schizophrenia: a 4-month follow-up study. Biological Psychiatry. 1999;46(3):392–400.
    1. Park S, Püschel J, Sauter BH, Rentsch M, Hell D. Spatial selective attention and inhibition in schizophrenia patients during acute psychosis and at 4-month follow-up. Biological Psychiatry. 2002;51(6):498–506.
    1. Pencer A, Addington J, Addington D. Outcome of a first episode of psychosis in adolescence: a 2-year follow-up. Psychiatry Research. 2005;133(1):35–43.
    1. Pogue-Geile ME, Harrow M. Negative and positive symptoms in schizophrenia and depression: a followup. Schizophrenia Bulletin. 1984;10(3):371–387.
    1. Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behavior Research Methods, Instruments, & Computers. 2004;36(4):717–731.
    1. Ragland JD, Censits DM, Gur RC, Glahn DC, Gallacher F, Gur RE. Assessing declarative memory in schizophrenia using Wisconsin Card Sorting Test stimuli: the Paired Associate Recognition Test. Psychiatry Res. 1996 Mar 29;60(2–3):135–145.
    1. Rhinewine JP, Lencz T, Thaden EP, et al. Neurocognitive profile in adolescents with early-onset schizophrenia: clinical correlates. Biological Psychiatry. 2005;58(9):705–712.
    1. Robert PH, Lafont V, Medecin I, Berthet L, Thauby S, Baudu C, Darcourt GUY. Clustering and switching strategies in verbal fluency tasks: comparison between schizophrenics and healthy adults. Journal of the International Neuropsychological Society. 1998;4(06):539–546.
    1. Rocca P, Bellino S, Calvarese P, Marchiaro L, Patria L, Rasetti R, Bogetto F. Depressive and negative symptoms in schizophrenia: different effects on clinical features. Comprehensive Psychiatry. 2005;46(4):304–310.
    1. Rocca P, Castagna E, Marchiaro L, Rasetti R, Rivoira E, Bogetto E. Neuropsychological correlates of reality distortion in schizophrenic patients. Psychiatry Research. 2006;145(1):49–60.
    1. Rosenthal R. Meta-analytic Procedures for Social Research. Sage Pubns; 1991.
    1. Roy MA, DeVriendt X. Positive and negative symptoms in schizophrenia: a current overview. Canadian Journal of Psychiatry. 1994;39(7):407–414.
    1. Rund BR, Melle I, Friis S, Larsen TK, Midbøe LJ, Opjordsmoen S, Simonsen E, Vaglum P, McGlashan T. Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis. American Journal of Psychiatry. 2004 Mar;61(3):466–472.
    1. Rund BR, Landro NI, Orbeck AL. Stability in cognitive dysfunctions in schizophrenic patients. Psychiatry Research. 1997;69:131–141.
    1. Salem JE, Kring AM. Flat affect and social skills in schizophrenia: evidence for their independence. Psychiatry Research. 1999;87(2–3):159–167.
    1. Salokangas RK. Living situation, social network and outcome in schizophrenia: a five-year prospective follow-up study. Acta Psychiatrica Scandinavica. 1997;96(6):459–468.
    1. Saykin AJ, Shtasel DL, Gur RE, Kester DB, Mozley LH, Stafiniak P, Gur RC. Neuropsychological deficits in neuroleptic naive patients with first episode schizophrenia. Archives of General Psychiatry. 1994;51:124–131.
    1. Schuepbach D, Keshavan MS, Kmiec JA, Sweeney JA. Negative symptom resolution and improvements in specific cognitive deficits after acute treatment in first-episode schizophrenia. Schizophrenia Research. 2002;53(3):249–261.
    1. Sergi MJ, Rassovsky Y, Nuechterlein KH, Green ME. Social perception as a mediator of the influence of early visual processing on functional status in schizophrenia. American Journal of Psychiatry. 2006 Mar;163(3):448–454.
    1. Silver H, Shlomo N. Perception of facial emotions in chronic schizophrenia does not correlate with negative symptoms but correlates with cognitive and motor dysfunction. Schizophrenia Research. 2001;52(3):265–273.
    1. Simon AE, Giacomini V, Ferrera E, Mohr S. Is executive function associated with symptom severity in schizophrenia? European Archives Psychiatry and Clinical Neuroscience. 2003;253:216–218.
    1. Shean G, Burnett T, Eckman FS. Symptoms of schizophrenia and neurocognitive test performance. J Clin Psychol. 2002;58(7):723–731.
    1. Smith TE, Hull JW, Huppert JD, Silverstein SM. Recovery from psychosis in schizophrenia and schizoaffective disorder: symptoms and neurocognitive rate-limiters for the development of social behavior skills. Schizophrenia Research. 2002;55:229–237.
    1. Startup M, Jackson MC, Bendix S. The concurrent validity of the Global Assessment of Functioning (GAF) British Journal of Clinical Psychology. 2002;41(4):417–422.
    1. Stratta P, Daneluzzo E, Bustini M, Prosperini P, Rossi A. Processing of context information in schizophrenia: relation to clinical symptoms and WCST performance. Schizophrenia Research. 2000;44(1):57–67.
    1. Suslow T, Schonauer K, Ohrmann P, Eikelmann B, Reker T. Prediction of work performance by clinical symptoms and cognitive skills in schizophrenic outpatients. Journal of Nervous and Mental Disease. 2000;188:116–118.
    1. Van der Does AJW, Dingemans P, Linszen DH, Nugter MA, Scholte WF. Symptoms, cognitive and social functioning in recent-onset schizophrenia: a longitudinal study. Schizophrenia Research. 1996;19(1):61–71.
    1. Villalta-Gil V, Vilaplana M, Ochoa S, Haro JM, Dolz M, Usall J, Cervilla J. Neurocognitive performance and negative symptoms: are they equal in explaining disability in schizophrenia outpatients? Schizophrenia Research. 2006;87(1–3):246–253.
    1. Wegener S, Redoblado-Hodge MA, Lucas S, Fitzgerald D, Harris A, Brennan J. Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. Australian and New Zealand Journal of Psychiatry. 2005;39(6):487–492.
    1. Zakzanis KK. Neuropsychological correlates of positive vs. negative schizophrenic symptomatology. Schizophrenia Research. 1998;29(3):227–233.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever